Sign up
Pharma Capital

Launch of CellPlan set to generate maiden revenues - WideCells CEO Joao Andrade

WideCells Group PLC (LON:WDC)  chief executive Joao Andrade and non-executive director Dr Marilyn Orcharton tell Proactive's Andrew Scott they're now fully authorised to sell CellPlan in the UK, Portugal and Spain.

 

 

View full WDC profile View Profile
View All

© biotech Capital 2018

Biotech Capital, a subsidiary of Proactive Investors, acts as the vanguard for listed biotech companies to interact with institutional and highly capitalised investors.
Headquartered in London, Biotech Capital is led by a team of Europe's leading analysts and journalists, publishing daily content, covering all key movements in the Biotechnology market.